Syngene International has extended its strategic research collaboration with Bristol Myers Squibb through 2035, expanding integrated services across discovery, development, manufacturing, and clinical programs.
AbbVie today reported positive topline results from its Phase 3 EPCORE DLBCL-1 trial, showing epcoritamab improved progression-free survival in adults with relapsed or refractory diffuse large B-cell lymphoma.
Entod Pharmaceuticals has developed the world's first losartan eye drops to treat corneal scarring, a major cause of vision loss. The innovation marks a global milestone in ophthalmic drug formulation.
Dr. Reddy's Laboratories has introduced the OTC Olopatadine Hydrochloride Ophthalmic Solution USP, 0.7% in the U.S. market, offering relief from itchy eyes due to common allergens. This first-to-market launch reinforces the company's growing presence
Alembic Pharmaceuticals has received tentative approval from the US Food & Drug Administration for its supplemental Abbreviated New Drug Application (sANDA) for Bosutinib tablets, 400 mg, strengthening the company’s US oncology generics market pre...
The World Health Organization today released WHO HIV clinical guidelines that set a new direction for HIV treatment, prevention, and tuberculosis care, reflecting major scientific progress since the last update in 2021...
Abbott launches Libre Assist at CES 2026, a smart Libre app feature using AI and CGM data to guide meal choices and predict glucose impact for people with diabetes.
.jpeg)
Dr Reddy’s launches Hevaxin, India’s only DCGI-approved hepatitis E vaccine, offering long-term immunity and supporting national efforts to reduce liver disease burden.
AstraZeneca today announced positive phase III clinical data for baxdrostat, an investigational oral therapy being developed for patients with uncontrolled or resistant hypertension. The results strengthen baxdrostat’s position as a potential...
Health ministry bans oral nimesulide above 100 mg for human use after DTAB and ICMR review, citing safety risks, second-line therapy use, and safer drug alternatives.
.jpg)
.jpg)
, CDSCO.jpg)